VitalityXtra Capsules, 500 mg, packaged in 10 count blisters in cartons, Distributed by: Vitality...

FDA Recall #D-0083-2025 — Class I — November 4, 2024

Recall #D-0083-2025 Date: November 4, 2024 Classification: Class I Status: Ongoing

Product Description

VitalityXtra Capsules, 500 mg, packaged in 10 count blisters in cartons, Distributed by: VitalityXtra, San Francisco, CA www.vitalityxtra.com

Reason for Recall

Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.

Recalling Firm

Boulla LLC — Sacramento, CA

Classification

Class I — Reasonable probability of serious adverse health consequences or death.

Product Type

Drugs

Product Quantity

Unknown

Distribution

Nationwide within the United States

Code Information

Lot #: 230811, Exp: 08/11/2025

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated